These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 39106048)

  • 1. Impact of rapid-antiretroviral therapy in a cohort of treatment-naïve migrants living with HIV in a high income setting.
    Trevisan S; Gasparro G; Kiros ST; Pozzi M; Malcontenti C; Campolmi I; Paggi R; Cavallo A; Farese A; Ducci F; Meli M; Pittorru M; Bartoloni A; Sterrantino G; Lagi F
    Int J STD AIDS; 2024 Oct; 35(11):858-864. PubMed ID: 39106048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Initiation of Antiretroviral Therapy Under the Treat-All Policy Reduces Loss to Follow-Up and Virological Failure in Routine Human Immunodeficiency Virus Care Settings in China: A Retrospective Cohort Study (2016-2022).
    Xia H; Li L; Wu Y; Gao L; Zhang D; Ma P
    AIDS Patient Care STDS; 2024 Apr; 38(4):168-176. PubMed ID: 38656215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort.
    Saracino A; Lorenzini P; Lo Caputo S; Girardi E; Castelli F; Bonfanti P; Rusconi S; Caramello P; Abrescia N; Mussini C; Monno L; d'Arminio Monforte A;
    Clin Microbiol Infect; 2016 Mar; 22(3):288.e1-8. PubMed ID: 26551839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004-2012: a cohort study.
    Mberi MN; Kuonza LR; Dube NM; Nattey C; Manda S; Summers R
    BMC Health Serv Res; 2015 Jul; 15():259. PubMed ID: 26141729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disclosure of HIV status and its impact on the loss in the follow-up of HIV-infected patients on potent anti-retroviral therapy programs in a (post-) conflict setting: A retrospective cohort study from Goma, Democratic Republic of Congo.
    Akilimali PZ; Musumari PM; Kashala-Abotnes E; Kayembe PK; Lepira FB; Mutombo PB; Tylleskar T; Ali MM
    PLoS One; 2017; 12(2):e0171407. PubMed ID: 28170410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Same-day ART initiation, loss to follow-up and viral load suppression among people living with HIV in low- and middle-income countries: systematic review and meta-analysis.
    Bakari HM; Alo O; Mbwana MS; Salim SM; Ludeman E; Lascko T; Ramadhani HO
    Pan Afr Med J; 2023; 46():92. PubMed ID: 38405092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of a cohort of migrants and citizens living with human immunodeficiency virus in Botswana: implications for Joint United Nation Program on HIV and AIDS 90-90-90 targets.
    Marukutira T; Yin D; Cressman L; Kariuki R; Malone B; Spelman T; Mawandia S; Ledikwe JH; Semo BW; Crowe S; Stoove M; Hellard M; Dickinson D
    Medicine (Baltimore); 2019 Jun; 98(23):e15994. PubMed ID: 31169739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss to follow-up and its predictors among children living with HIV on antiretroviral therapy, southern Oromia, Ethiopia: a 5-year retrospective cohort study.
    Bankere AW; Daba SG; Ami B; Gedefa LK; Lencha B
    BMJ Open; 2024 Jul; 14(7):e078370. PubMed ID: 39089715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective assessment of loss to follow-up: incidence and associated factors in a cohort of HIV-positive adults in rural Tanzania.
    Kalinjuma AV; Glass TR; Weisser M; Myeya SJ; Kasuga B; Kisung'a Y; Sikalengo G; Katende A; Battegay M; Vanobberghen F;
    J Int AIDS Soc; 2020 Mar; 23(3):e25460. PubMed ID: 32128998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of the observed high prevalence of loss to follow-up in ART-experienced adult PLHIV: a retrospective longitudinal cohort study in the Tanga Region, Tanzania.
    Mushy SE; Mtisi E; Mboggo E; Mkawe S; Yahya-Malima KI; Ndega J; Ngalesoni F; Muya A
    BMC Infect Dis; 2023 Feb; 23(1):92. PubMed ID: 36788523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heavily treatment-experienced persons living with HIV currently in care in Italy: characteristics, risk factors, and therapeutic options-the ICONA Foundation cohort study.
    Lo Caputo S; Poliseno M; Tavelli A; Gagliardini R; Rusconi S; Lapadula G; Antinori A; Francisci D; Sarmati L; Gori A; Spagnuolo V; Ceccherini-Silberstein F; d'Arminio Monforte A; Cozzi-Lepri A;
    Int J Infect Dis; 2024 Jun; 143():106956. PubMed ID: 38447754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does gender or mode of HIV acquisition affect virological response to modern antiretroviral therapy (ART)?
    Saunders P; Goodman AL; Smith CJ; Marshall N; O'Connor JL; Lampe FC; Johnson MA
    HIV Med; 2016 Jan; 17(1):18-27. PubMed ID: 26140659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral therapy programme outcomes at Senkatana antiretroviral therapy clinic, Lesotho: a four-year retrospective cohort study.
    Kabuya M; Musekiwa A; Takuva S; Thabane L; Mbuagbaw L
    Pan Afr Med J; 2023; 46():74. PubMed ID: 38282767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective cross sectional study assessing factors associated with retention and non-viral suppression among HIV positive FSWs receiving antiretroviral therapy from primary health care facilities in Kampala, Uganda.
    Atuhaire L; Shumba CS; Mapahla L; Nyasulu PS
    BMC Infect Dis; 2022 Jul; 22(1):642. PubMed ID: 35883042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracking People Living with HIV in Loss to Follow Up in Central Brazil: A Call for Attention to Health Services.
    da Silva ASP; Amianti C; Bandeira LM; Júnior RB; Faccin GM; Motta-Castro ARC
    AIDS Behav; 2024 Jul; 28(7):2403-2409. PubMed ID: 38720109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
    Prendergast A; Mphatswe W; Tudor-Williams G; Rakgotho M; Pillay V; Thobakgale C; McCarthy N; Morris L; Walker BD; Goulder P
    AIDS; 2008 Jul; 22(11):1333-43. PubMed ID: 18580613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
    Alvarez-Uria G; Naik PK; Pakam R; Midde M
    Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral therapy uptake and predictors of virological failure in patients with HIV receiving first-line and second-line regimens in Johannesburg, South Africa: a retrospective cohort data analysis.
    Gumede SB; Venter F; de Wit J; Wensing A; Lalla-Edward ST
    BMJ Open; 2022 Apr; 12(4):e054019. PubMed ID: 35428623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.